Article 1
Chapter I of Annex B to Directive 70/524/EEC is amended as follows: The additive monensin sodium, belonging to the group ‘Coccidiostats and other medical substances’, shall be deleted.
Commission Regulation (EC) No 1356/2004 of 26 July 2004 concerning the authorisation for 10 years of the additive «Elancoban» in feedingstuffs, belonging to the group of coccidiostats and other medicinal substances(Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Chapter I of Annex B to Directive 70/524/EEC is amended as follows: The additive monensin sodium, belonging to the group ‘Coccidiostats and other medical substances’, shall be deleted.
The additive Elancoban belonging to the group ‘Coccidiostats and other medical substances’, as set out in the Annex to the present Regulation is authorised for use in animal nutrition under the conditions laid down in that Annex.
A period of six months from the date of entry into force of this Regulation is permitted to use up the existing stocks of monensin sodium.
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
ANNEX Registration number of additive Name and registration number of person responsible for putting the additive into circulation Additive (trade name) Composition, chemical formula, description Species or category of animal Maximum age Minimum content Maximum content Other provisions Period of authorisation mg of active substance/kg of complete feedingstuff Coccidiostats and other medicinal substances ‘E 757 Eli Lilly and Company Limited Monensin sodium Active substance: C 36 H 61 O 11 Na sodium salt of polyether monocarboxylic acid produced by Streptomyces cinnamonensis , ATCC 15413 in granular form. Factor composition: Monensin A: not less than 90 % Monensin: A + B: not less than 95 % Chickens for fattening — 100 125 Use prohibited at least three days before slaughter. Indicate in the instructions for use: Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances. 30.7.2014’ Elancoban G100 Elancoban 100 Elancogran 100 Additive composition: Granular monensin (dried fermentation product) equivalent to Monensin activity 10 % w/w Mineral oil 1-3 % w/w Limestone granular 13-23 % w/w Rice hulls or limestone granular qs 100 % w/w Chickens reared for laying 16 weeks 100 120 Indicate in the instructions for use: Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances. Elancoban G200 Elancoban 200 Granular monensin (dried fermentation product) equivalent to Monensin activity 20 % w/w Mineral oil 1-3 % w/w Rice hulls or limestone granular qs 100 % w/w Turkeys 16 weeks 60 100 Use prohibited at least three days before slaughter. Indicate in the instructions for use: Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.